Association between Dialysis Modality and Cardiovascular Diseases: A Comparison between Peritoneal Dialysis and

Masataka Banshodani1, Hideki Kawanishi2, Misaki Moriishi2

  • 1Department of Artificial Organs, Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan, m-banshodani@tsuchiya-hp.jp.

Blood Purification
|December 19, 2019
PubMed

Insights

Peritoneal dialysis (PD) increases the risk of cardiovascular disease (CVD) hospitalization and death in end-stage kidney disease (ESKD) patients compared to hemodialysis (HD). Careful fluid management is crucial for PD patients to prevent cardiovascular events.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality in patients with end-stage kidney disease (ESKD).
  • Dialysis modality, including peritoneal dialysis (PD) and hemodialysis (HD), may influence CVD risk in ESKD patients.

Purpose of the Study:

  • To investigate the association between dialysis modality (PD vs. HD) and the risk of CVD-related emergency hospitalization and mortality in ESKD patients.
  • To identify risk factors for CVD events in patients undergoing different dialysis treatments.

Main Methods:

  • A retrospective observational cohort study design was employed.
  • Propensity score matching was used to compare patients undergoing PD versus HD.
  • Cox proportional hazards regression models were utilized to evaluate risk factors for CVD events.

Main Results:

  • Patients on PD had significantly higher rates of emergency hospitalization for overall CVDs and pulmonary edema compared to those on HD.
  • All-cause and CVD-related mortality were significantly higher in the PD group.
  • PD was identified as a significant predictor of both emergency hospitalization and mortality for CVDs.

Conclusions:

  • Peritoneal dialysis is associated with an increased risk of cardiovascular disease hospitalization and mortality in ESKD patients.
  • Strict management of fluid balance in PD patients may be essential for mitigating cardiovascular risks.
  • These findings highlight the importance of considering dialysis modality when assessing CVD risk in ESKD.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.1K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.5K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
416
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
503
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
308